Scarica l'app Stockscreener
5.03
6.12%
0.29
Dopo l'orario di chiusura:
5.11
0.08
+1.59%
Precedente Chiudi:
$4.74
Aprire:
$4.76
Volume 24 ore:
49,360
Relative Volume:
0.16
Capitalizzazione di mercato:
$94.07M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+5.45%
1M Prestazione:
-12.98%
6M Prestazione:
-19.78%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.71
$5.12
Intervallo di 1 settimana:
$4.6017
$5.30
Portata 52W:
$2.14
$12.50
Kalaris Therapeutics Inc Stock (KLRS) Company Profile
Nome
Kalaris Therapeutics Inc
Settore
Industria
Telefono
650-249-2727
Indirizzo
628 MIDDLEFIELD ROAD, PALO ALTO
Confronta KLRS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KLRS
Kalaris Therapeutics Inc
|
5.03 | 88.65M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kalaris Therapeutics Inc Stock (KLRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Iniziato | Raymond James | Strong Buy |
| 2025-07-23 | Ripresa | Piper Sandler | Neutral |
| 2025-05-07 | Iniziato | Leerink Partners | Outperform |
| 2025-04-08 | Iniziato | William Blair | Outperform |
Kalaris Therapeutics Inc Borsa (KLRS) Ultime notizie
Tools to assess Kalaris Therapeutics Inc.’s risk profileDollar Strength & Safe Investment Capital Preservation Plans - newser.com
Can trapped investors hope for a rebound in Kalaris Therapeutics Inc.Market Trend Summary & Stepwise Swing Trade Plans - newser.com
Short Interest in Kalaris Therapeutics Inc. (NASDAQ:KLRS) Declines By 40.5% - MarketBeat
How resilient is Kalaris Therapeutics Inc. stock in market downturnsTrade Performance Summary & Safe Swing Trade Setups - newser.com
What to expect from Kalaris Therapeutics Inc. in the next 30 daysWeekly Trend Recap & Real-Time Volume Spike Alerts - newser.com
Will Kalaris Therapeutics Inc. outperform the marketProfit Target & Risk Controlled Stock Alerts - newser.com
How Kalaris Therapeutics Inc. stock performs in rate cut cyclesWeekly Trend Report & Consistent Income Trade Ideas - newser.com
What MACD and RSI say about Kalaris Therapeutics Inc.Weekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Is Kalaris Therapeutics Inc. stock positioned for digital transformationWatch List & Fast Entry Momentum Alerts - newser.com
Analyzing Kalaris Therapeutics Inc. with risk reward ratio chartsJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
Can Kalaris Therapeutics Inc. rally from current levelsRecession Risk & Verified Momentum Watchlists - newser.com
How to use a screener to detect Kalaris Therapeutics Inc. breakoutsJuly 2025 WrapUp & Weekly Watchlist of Top Performers - newser.com
Kalaris Therapeutics Inc. stock outlook for YEAR2025 Performance Recap & Community Verified Watchlist Alerts - newser.com
Published on: 2025-10-31 05:04:53 - newser.com
Identifying reversal signals in Kalaris Therapeutics Inc.Weekly Earnings Recap & Low Risk Investment Opportunities - newser.com
Kalaris to Present at Stifel 2025 Annual Healthcare Conference - Investing News Network
Kalaris (Nasdaq: KLRS) to present at Stifel Healthcare Conference; CEO & CMO 3:20–3:50 ET - Stock Titan
Leading vs lagging indicators on Kalaris Therapeutics Inc. performance2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Published on: 2025-10-30 01:28:32 - newser.com
How supply chain issues affect Kalaris Therapeutics Inc. stockJuly 2025 Reactions & Smart Allocation Stock Tips - fcp.pa.gov.br
Published on: 2025-10-28 03:17:08 - newser.com
Does Kalaris Therapeutics Inc. qualify in momentum factor screeningWeekly Risk Report & High Conviction Trade Alerts - newser.com
Kalaris Therapeutics Inc Azioni (KLRS) Dati Finanziari
Non sono disponibili dati finanziari per Kalaris Therapeutics Inc (KLRS). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):